A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People
Trial Summary
Will I have to stop taking my current medications?
Yes, you will need to stop taking any prescription or nonprescription drugs, as well as dietary and herbal supplements, at least 28 days before the first dose of the study medicine.
What is the purpose of this trial?
This trial tests a new COVID-19 medicine called PF-07817883 in healthy people. It aims to see if the medicine is safe and how it moves through the body. The study also looks at how food and other drugs might affect the medicine.
Research Team
Pfizer CT.gov Call Center
Principal Investigator
Pfizer
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Single Ascending Dose
Participants receive single ascending doses of PF-07817883 to evaluate safety and pharmacokinetics
Multiple Ascending Dose
Participants receive multiple ascending doses of PF-07817883 to evaluate safety and pharmacokinetics
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- PF-07817883
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pfizer
Lead Sponsor
Albert Bourla
Pfizer
Chief Executive Officer since 2019
PhD in Biotechnology of Reproduction, Aristotle University of Thessaloniki
Patrizia Cavazzoni
Pfizer
Chief Medical Officer
MD from McGill University